BetterScholar BetterScholar
11
Role
Title
Level Year L/R
🐜 Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
18 auth. M. Kriege, C. Brekelmans, C. Boetes, Peter E. Besnard, H. Zonderland, I. Obdeijn, R. Manoliu, T. Kok, H. Peterse, M. Tilanus-Linthorst, ... S. Muller, S. Meijer, J. Oosterwijk, L. Beex, R. Tollenaar, H. D. de Koning, E. Rutgers, J. Klijn
10 2004
10
🐜
🐜 Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer.
9 auth. E. Deurloo, P. Tanis, K. Gilhuijs, S. Muller, R. KrΓΆger, J. Peterse, ... E. Rutgers, R. V. ValdΓ©s Olmos, L. S. Schultze Kool
8 2003
8
🐜
🐜 Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype.
7 auth. C. Loo, M. Straver, S. Rodenhuis, S. Muller, J. Wesseling, M. V. Vrancken Peeters, ... K. Gilhuijs
8 2011
8
🐜
🐜 Portal imaging to assess set-up errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer.
8 auth. S. Erridge, Y. Seppenwoolde, S. Muller, M. V. van Herk, K. de Jaeger, J. Belderbos, ... L. Boersma, J. Lebesque
8 2001
8
🐜
🐜 BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.
23 auth. A. Rijnsburger, I. Obdeijn, R. Kaas, M. Tilanus-Linthorst, C. Boetes, C. Loo, M. Wasser, E. Bergers, T. Kok, S. Muller, ... H. Peterse, R. Tollenaar, N. Hoogerbrugge, S. Meijer, C. Bartels, C. Seynaeve, M. Hooning, M. Kriege, P. Schmitz, J. Oosterwijk, H. D. de Koning, E. Rutgers, J. Klijn
7 2010
7
🐜
🐜 Breast tomosynthesis in clinical practice: initial results
7 auth. H. Teertstra, C. Loo, M. A. Bosch, H. Tinteren, E. Rutgers, S. Muller, ... K. Gilhuijs
7 2009
7
🐜
🐜 Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis.
8 auth. S. Kwa, J. Theuws, Antoinette C. Wagenaar, E. Damen, L. Boersma, P. Baas, ... S. Muller, J. Lebesque
7 1998
7
🐜
🐜 Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer.
7 auth. Y. Seppenwoolde, S. Muller, J. Theuws, P. Baas, J. Belderbos, L. Boersma, ... J. Lebesque
6 2000
6
🐜
🐬 Additional breast lesions in patients eligible for breast-conserving therapy by MRI: impact on preoperative management and potential benefit of computerised analysis.
E. Deurloo, J. Peterse, E. Rutgers, A. Besnard, S. Muller, K. Gilhuijs
6 2005
6
🐬
🐜 Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer.
8 auth. J. Theuws, S. Kwa, A. Wagenaar, L. Boersma, E. Damen, S. Muller, ... P. Baas, J. Lebesque
6 1998
6
🐜
🐜 Optimizing radiation treatment plans for lung cancer using lung perfusion information.
11 auth. Y. Seppenwoolde, M. Engelsman, K. de Jaeger, S. Muller, P. Baas, D. McShan, ... B. Fraass, M. Kessler, J. Belderbos, L. Boersma, J. Lebesque
6 2002
6
🐜